Firastotug
Based on 1 Customer Validation
Firastotug (ADG116) is an anti-CTLA‑4 IgG1 antibody that exerts antitumor effects through partial blockade of CD80/86 and enhancement of ADCC-mediated intratumoral Treg depletion. Firastotug can be used in research related to advanced/metastatic solid tumors.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 98.62%
- CAS No.: 2750031-14-0
- Masse moléculaire:145.05 kDa
-
Stockage:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
IC50 & Target
CTLA4
In Vivo
Firastotug monotherapy and its combination with Toripalimab demonstrate manageable safety and considerable antitumor activity in advanced/metastatic solid tumors[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Essai clinique
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
Application
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized CTLA-4 Protein, Human (HEK293, HY-P72959) can bind Firastotug. The EC50 for this effect is 2.057 ng/mL. -
Flow Cytometry analysis of Raji cells labelling CTLA4 (red) with Firastotug (anti-CTLA4) (HY-P990041). Cells were stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).
Product Details
-
CAS No. 2750031-14-0
-
Accession P16410
-
Synonyms ADG116
-
Masse moléculaire 145.05 kDa
-
Species Reactivity
Human
-
Conjugated
Unconjugated
-
Isotype
Human IgG1 kappa
-
Recommend Isotype Controls
-
Format
-
Human IgG1 kappa
-
Product Properties
-
Appearance
Liquid
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Pureté
98.62%
-
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
-
Storage & Stability
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Livraison
Shipping with dry ice.
Pureté et documentation
-
Fiche technique (275 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
Références
Hot Topics
-
All
-
Topics
-
Most Recent
-
Oldest
-
Topics Immune Checkpoint: A Critical Target In Tumor Therapy
Immune checkpoints are inhibitory or costimulatory pathways that regulate T-cell activation, peripheral tolerance, and antitumor immune responses, and tumors can exploit these pathways to restrict effector T-cell function and establish immune escape.
2026-06-18
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)